AKT1 and hydrops fetalis: Additionally, CRISPR-Cas9 technology will be used to generate knockout mice for key genes such as FoxO3 and Akt1, combined with proteomics to dynamically track regulatory nodes in the HF cycle and map a precise “compound-target-pathway” regulatory network.